Abstract：Objective: To investigate the serum level of serum retinin and its clinical significance in patients with polycystic ovary syndrome (PCOS). Methods: 120 patients with PCOS admitted to our hospital from January 2016 to July 2016 were enrolled as PCOS group and 120 healthy volunteers were enrolled in this study as healthy control group. Meanwhile, Luteotropic hormone (LH), follicle stimulatin hormone (FSH), testosterone (T), estradiol (E2) and pituitary prolactin (PRL) Fasting serum insulin (FINS) and fasting blood glucose (FBG) were measured. The levels of homeostasis model assessment-insulin resistance (HOMA-IR) and serum retinal omentin. Results: The levels of serum LH and T in PCOS group were significantly higher than those in healthy control group (P <0.05), while the levels of serum FSH in PCOS group were significantly lower than those in healthy control group (P <0.05). The levels of FINS and HOMA-IR in PCOS group were higher (P <0.05). The level of serum Omentin in patients with PCOS was lower than that in healthy controls (P <0.05). The level of serum Omentin was negatively correlated with HOMA-IR index in patients with PCOS (R2 = 0.798; P <0.001) . Conclusions: The decline of serum Omentin will lead to the rise of insulin resistance and indirectly affect the blood glucose level of PCOS patients. It may be used as an adjunctive therapy for PCOS patients as the relevant laboratory index.
邓岳红. 多囊卵巢综合征患者血清网膜素水平及其临床意义[J]. 河北医学, 2018, 24(2): 232-235.
DENG Yuehong. Serum OPG in Patients with Polycystic Ovary Syndrome and its Clinical Significance. HeBei Med, 2018, 24(2): 232-235.
[1] Tan B K,Adya R,Farhatullah S,et al.Omentin-1,a novel adipokine,is decreased in overweight insulin-resistant women with polycystic ovary syndrome:ex vivo and in vivo regulation of omentin-1 by insulin and glucose[J].Diabetes,2008,57(4):801~808. [2] Barber T M,Stephen F.Genetics of polycystic ovary syndrome[J].International Journal of Gynecology&Obstetrics,2013,70(3):177~182. [3] Ben-Shlomo I,Younis J S.Basic research in PCOS:are we reaching new frontiers[J].Reproductive Biomedicine Online,2014,28(6):669~683. [4] 裴友娟,王蔼明,闫玲,等.多囊卵巢综合征患者静息心率与糖脂代谢及血压等指标关系的研究[J].生殖医学杂志,2013,22(2):114~118. [5] 罗小雨,彭菊兰,吴璇华.多囊卵巢综合征患者血清内脂素、脂联素的变化及意义[J].海南医学院学报,2013,19(10). [6] 谢家滨.血浆内脂素水平在多囊卵巢综合征患者中的变化及意义[J].河北医学,2014(11):1791~1793. [7] 李浩彦,任明.血清网膜素1相关研究进展[J].中西医结合心脑血管病杂志,2016,14(7):722~725. [8] 陆新虹,杨海燕,罗佐杰,等.多囊卵巢综合征患者血清网膜素水平变化及其意义[J].中华内分泌代谢杂志,2015,31(10):880~882. [9] 王莉,尹利荣,徐燕颖,等.肥胖与非肥胖型多囊卵巢综合征患者血清胃促生长素分泌特点与发病机制探讨[J].天津医药,2013,41(5):416~418. [10] 岑振考,叶恒君.探讨多囊卵巢综合征患者检测血清LH、FSH、TSTO的意义[J].中国现代药物应用,2015(12):29~30. [11] 孙叶,任青玲.PCOS发病因素的中西医研究进展[J].当代医药论丛,2015(5):155~157. [12] Jeon Y E,Lee K E,Jung J A,et al.Kisspeptin,leptin,and retinol-binding protein 4 in women with polycystic ovary syndrome[J].Gynecologic&Obstetric Investigation,2013,75(4):268~274. [13] 王楠楠,赵晓娟,陈薇,等.大鼠血清网膜素-1水平与胰岛素抵抗的相关性[J].中国病理生理杂志,2014,30(12):2276~2279. [14] 陆水英(综述),陈衡(审校).瘦素和网膜素在妇产科领域研究进展[J].中华实用诊断与治疗杂志,2014,28(3):215~217.
2018, Vol. 24 
冀公网安备13080202000677号